Asia Pacific Ultra-Low Temperature Freezer Market Developments and Forecast by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Asia Pacific Ultra-Low Temperature Freezer Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type (Upright ULT freezers, Chest ULT freezers); End User (Bio-Banks, Hospital, Pharmaceutical and Biotechnology Companies, Academic and Research Institute); and, Country

  • Report Date : Aug 2020
  • Report Code : TIPRE00012982
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 96
Page Updated: Oct 2020

Asia Pacific, the ultra-low temperature freezer market, is anticipated to reach US$ 159.04 Mn in 2027 from US$ 109.02 Mn in 2019. The market is projected to grow with a CAGR of 5.0% from 2020-2027.

The ultra-low temperature freezer market is growing primarily due to growing R&D activities to introduce new drug compounds. Restraining factor such as, high costs associated with ultra-low temperature freezers is likely to damage the growth of the market in the coming years. On the other hand, development in the healthcare market is expected to have a positive impact on the growth of the Asia Pacific ultra-low temperature freezer market in the coming years.

The healthcare industry has been witnessing rapid transformations during the previous years. The industry has witnessed various technological advancements, such as use of stem cell therapy and personalized medicine. Countries across the globe have been preferring advanced technologies in healthcare. With a need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being preferred in the healthcare systems in emerging economies. In addition, the increase in aging population, incidences of chronic illnesses and pediatric care are the primary factors driving the growth of the healthcare sector.

Various established players in the industry have been investing significant amount of their revenue in R&D activities for the development of better and advanced products and technologies to be used in the healthcare industry. Also, the availability of reimbursement for various medical procedures are expected to fuel the growth of the industry in the coming years.

There has been a significant increase in the healthcare expenditure during the previous years. As per World Bank, Healthcare expenditure accounts for 9.94% of global GDP. In the US, 17.1% of its GDP is committed to the industry, whereas in Latin America, HC expenditures account for only 7.24%, with Brazil at 8.3%, and Mexico at 6.3%. Whereas the healthcare expenditure per capita was 5.6%, and 4.7% in China, and India, respectively, during 2017. The above stated factors are expected to offer broad growth opportunities in the market.

As per the S&P Global ratings, the coronavirus is expected to wipe approximately US$200 billion off Asia Pacific economies this year, sending growth to its lowest level, as governments across the region struggle to combat the disease. The outbreak has spread to at least 85 countries in the region and is expected to hammer markets as investors fret over its economic impact. In china, the reported total cases of coronavirus are 82,295; in Japan, it is 8,100; India is having 11,555 counts. on a large scale, the pharmaceutical companies are working on drug discovery and clinical testing processes in the regions. China and Japan have been frontiers in the research activities including development of stem cell therapies, cell therapies and regenerative medicine. Thus, the ultra-low temperature freezer market is anticipated to less affected by the pandemic situation.

In 2019, the Japan accounted for the largest market share in Asia Pacific ultra-low temperature freezer market, and it is also expected to grow at a faster pace over the forecast period. In the country, the market players are focusing on new product launches and increasing adoption and acceptance of ultra-low temperature freezer. Moreover, the market players are focusing on manufacturing energy-efficient natural refrigerants and inverter compressors to reduce power consumption through slow-speed rotation control effectively, which are responsible for the highest revenue share of the region. Hence, considering the mentioned factors, the ultra-low temperature freezer market is expected to grow at a significant pace in the US during the forecast period.


Rest of Asia Pacific Ultra-Low Temperature Freezer Market Revenue and Forecasts to 2027 (US$ Mn)

12593-img1

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

ASIA PACIFIC ULTRA-LOW TEMPERATURE FREEZER – MARKET SEGMENTATION

By Type

  • Upright ULT Freezers
  • Chest ULT Freezers

By End-User

  • Bio-Banks
  • Hospital
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute

By Geography

  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea

Company Profiles

  • Bionics Scientific Technologies (P). Ltd
  • Haier Biomedical
  • REMI GROUP
  • PHC Holdings Corporation
  • Esco Group of Companies

Asia Pacific Ultra-Low Temperature Freezer Report Scope

Report Attribute Details
Market size in 2019 US$ 109.02 Million
Market Size by 2027 US$ 159.04 Million
Global CAGR (2020 - 2027) 5.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Upright ULT freezers
  • Chest ULT freezers
By End User
  • Bio-Banks
  • Hospital
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Bionics Scientific Technologies (P). Ltd
  • Haier Biomedical
  • REMI GROUP
  • PHC Holdings Corporation
  • Esco Group of Companies
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo